Picture of Biosynex SA logo

ALBIO Biosynex SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapTurnaround

Brief: Biosynex H1 Net Result Up At 70.5 Million Euros

Oct 20 (Reuters) - BIOSYNEX SA  ALBIO.PA :
    * H1 CONSOLIDATED NET RESULT EUR 70.5 MILLION VERSUS EUR 6.2
MILLION YEAR AGO
    * H1 REVENUE EUR 225.2 EUR VERSUS 44.1 MILLION YEAR AGO
    * H1 GROSS OPERATING PROFIT EUR 98.3 MILLION VERSUS EUR 8.6
MILLION YEAR AGO
    * AS AN EXTENSION OF THE PRESS RELEASE PUBLISHED ON OCTOBER
14,
BIOSYNEX WILL INTENSIFY ITS EFFORTS TO PENETRATE NEW COUNTRIES
FOR ITS SARS-COV TESTS
    * CASH POSITION PROVIDES THE GROUP WITH NECESSARY RESOURCES
TO
ENSURE ITS DEVELOPMENT AND CARRY OUT FUTURE EXTERNAL GROWTH
OPERATIONS
    * THE STRONG CASH GENERATION FROM THE LAST 12 MONTHS NOW
GIVES
BIOSYNEX THE MEANS TO FULFILL ITS AMBITIONS IN TERMS OF EXTERNAL
GROWTH
    * GROSS FINANCIAL DEBT REACHED €23.0 MILLION AT THE END OF
JUNE
2021 COMPARED TO €15.8 MILLION SIX MONTHS EARLIER

Source text for Eikon:  ID:nBw9lzLRba 
Further company coverage:  ALBIO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00 ;))

Recent news on Biosynex SA

See all news